Search

everythinglearnresearchcommunity

for

Search:↓

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Reduced TRPS1 leads to increased STAT3 and SOX9 in hair follicles, affecting hair growth.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

TH07 effectively promotes hair regrowth in androgenic alopecia with high patient satisfaction and no major side effects.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.